Porcine Vaccines Market (Disease Indication Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Based on technology, the porcine vaccines market has been segmented into inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines. These market segments have been extensively analyzed based on increase in the demand for treatment of diseases such as PED, PRRS, and PCVAD. Surging demand for disease-free pork meat and increasing awareness for treating cultivated pigs are driving the technology segments of the market. Different types of end-users utilize porcine vaccines to treat swine diseases. Among end-users, the hog production farms segment holds a major share, followed by the veterinary hospitals segment. The market size (in terms of US$ Mn) and forecast for each segment have been provided for the period from 2015 to 2025. The report also provides the compounded annual growth rate (CAGR %) for each segment for the period from 2017 to 2025, considering 2016 as the base year.

Based on disease indication, the market has been segmented into diarrhoea, swine influenza, porcine reproductive and respiratory syndrome (PRRS), porcine circovirus associated disease (PCVAD), and others. Diarrhoea is the most widespread disease among pigs across the world. Porcine epidemic diarrhea virus (PEDV) hit the U.S. in 2013 and spread to Canada in 2014, which infected piglets. It had 80%–100% mortality rate. The above-mentioned segments have been analyzed based on available approved products, their cost-effectiveness, and preference by veterinarians for treating swine with various disease indications. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global porcine vaccines market has been categorized into five major regions and key countries/sub-regions in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, Russia, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competition scenario in the market in these regions.

The report also profiles major players in the global porcine vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report are Bayer AG., Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco (Eli Lilly and Company), Merck & Co., Inc., Vetoquinol, and Zoetis Inc.

The global porcine vaccines market has been segmented as below:

Global Porcine Vaccines Market, by Disease Indication, 2015–2025
Diarrhea
Swine Influenza
Arthritis
Bordetella Rhinitis
Porcine Reproductive and Respiratory Syndrome (PRRS)
Porcine Circovirus Associated Disease (PCVAD)
Others (CHRS, Leptospirosis, etc.)

Global Porcine Vaccines Market, by Technology, 2015–2025
Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
DNA Vaccines

Global Porcine Vaccines Market, by End-user, 2015–2025
Veterinary Hospitals
Hog Production Farms

Global Porcine Vaccines Market, by Geography, 2015–2025
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia

Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand

Rest of Asia Pacific
Latin America
Brazil
Mexico

Rest of Latin America
Middle East & Africa
South Africa

Rest of Middle East & Africa

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.